Marina Gaínza-Lein; Iván Sánchez Fernández, MD, MPH; Michele Jackson, MS; et al.
free access
JAMA Neurol. 2018;75(4):410-418. doi:10.1001/jamaneurol.2017.4382
This cohort study examines the association between delay in initiation of first-line benzodiazepine treatment and short-term outcomes for children hospitalized with refractory convulsive status epilepticus.
Dawn M. Bravata, MD; Laura J. Myers, PhD; Greg Arling, PhD; et al.
free access
JAMA Neurol. 2018;75(4):419-427. doi:10.1001/jamaneurol.2017.4648
This cohort study assesses the quality of guideline-recommended transient ischemic attack and minor stroke care across the Veterans Health Administration system nationwide.
Lidia Stork, MD; David Ellenberger, MS; Tim Beißbarth, PhD; et al.
free access
JAMA Neurol. 2018;75(4):428-435. doi:10.1001/jamaneurol.2017.4842
This cohort study evaluates the differences in response to apheresis treatment of patients with 3 histopathologically defined immunopathological patterns of multiple sclerosis.
Sang-Beom Jeon, MD, PhD; Chang Hwan Sohn, MD, PhD; Dong-Woo Seo, MD, PhD; et al.
free access
JAMA Neurol. 2018;75(4):436-443. doi:10.1001/jamaneurol.2017.4618
This study examines whether acute brain lesions on diffusion-weighted imaging are related to delayed neurological sequelae after carbon monoxide poisoning.
The Vitamin E in Neuroprotection Study (VENUS) Investigators
free access
JAMA Neurol. 2018;75(4):444-452. doi:10.1001/jamaneurol.2017.4609
This randomized clinical trial evaluates the efficacy of oral mixed tocotrienols for patients with diabetic peripheral neuropathy.
W. Taylor Kimberly, MD, PhD; Bruna Garbugio Dutra, MD; Anna M. M. Boers, MSc; et al.
free access
JAMA Neurol. 2018;75(4):453-461. doi:10.1001/jamaneurol.2017.5162
This study examines the association between reperfusion and brain edema in patients with acute ischemic stroke.
Alina Solomon, MD, PhD; Heidi Turunen, BM; Tiia Ngandu, MD, PhD; et al.
free access
JAMA Neurol. 2018;75(4):462-470. doi:10.1001/jamaneurol.2017.4365
This subgroup analysis of a randomized clinical trial examines whether the apolipoprotein E ε4 allele modifies the previously reported significant cognitive benefits of a multidomain lifestyle intervention.
Claus Z. Simonsen, MD, PhD; Albert J. Yoo, MD, PhD; Leif H. Sørensen, MD; et al.
free access
JAMA Neurol. 2018;75(4):470-477. doi:10.1001/jamaneurol.2017.4474
This randomized clinical trial analyzes the effect of general anesthesia and conscious sedation on infarct growth and clinical outcome of patients who underwent endovascular therapy for acute ischemic stroke.
Yael Hacohen, MD, DPhil; Yu Yi Wong, MD; Christian Lechner, MD; et al.
free access
JAMA Neurol. 2018;75(4):478-487. doi:10.1001/jamaneurol.2017.4601
This multinational cohort study examines the clinical phenotypes, treatment responses, and outcomes of children with relapsing myelin oligodendrocyte glycoprotein antibody–associated disease.
Yen Ying Lim, PhD; Pawel Kalinowski, PhD; Robert H. Pietrzak, PhD, MPH; et al.
free access
JAMA Neurol. 2018;75(4):488-494. doi:10.1001/jamaneurol.2017.4325
This longitudinal study examines the association of age, β-amyloid levels, and the apolipoprotein E ε4 allele with memory decline in a large group of cognitively healthy older adults enrolled in the Australian Imaging, Biomarkers, and Lifestyle study.
Mathilde Renaud, MD, PhD; Maria-Céu Moreira, PhD; Bondo Ben Monga, PhD; et al.
free access
has multimedia
JAMA Neurol. 2018;75(4):495-502. doi:10.1001/jamaneurol.2017.4373
This study defines the clinical, biomarker, and molecular spectrum and provides genotype-phenotype correlations among patients with ataxia with oculomotor apraxia type 1 from 18 countries.